MNK News and Press, Mallinckrodt plc From 03/11/21

Members of the Sackler family who own Purdue Pharma raised their settlement offer in ongoing opioid litigation to $4.3b from $3b, according to a Reuters report.Sackler family members are offering to contribute $4.3b to help settle thousands of lawsuits from U.S. communities that are trying to...

Mallinckrodt Gains Support for Its Restructuring Support Agreement from Lenders Holding Approximately $1.3 Billion of Its First Lien Term Loans PR Newswire DUBLIN , March 10, 2021 /PRNewswire/ -- Mallinckrodt plc (OTCMKTS: MNKKQ) (" Mallinckrodt " or the...

Vallon Pharmaceuticals has filed to raise $15 million in an IPO. The firm is developing reformulated treatments for ADHD and narcolepsy. VALL is a tiny and thinly capitalized firm. While I wish it well, I'll pass on the IPO. For further details see: IPO Update: Vallon Ph...

The company’s proposed RSA (Restructuring Support Agreement) provides for no repayment to the first-lien debtholders thus leading to looming debt maturities, and liquidity and refinancing risk. Factors like Covid-19 impact, loss of exclusivity for Ofirmev coupled with one-time ...

Mallinckrodt (MNK) initiates a retrospective chart review study to collect real-world data on the use of INOmax (nitric oxide) gas for inhalation therapy in COVID-19 patients with respiratory complications.The company will work with Pharmerit to collect data from ~200 hospitalized adult patie...

Vallon Pharmaceuticals has filed to raise $17 million in a U.S. IPO. The firm is developing reformulated drug treatment candidates for ADHD and narcolepsy. VALL is related to investor Arcturus Therapeutics, from whom it obtained its core technologies. For further details see...

Mallinckrodt Announces Data at Kidney Week 2020 Reimagined that Showed A Potential for Reduced Need for Renal Replacement (RRT) Therapy for Patients with Hepatorenal Syndrome Type 1 (HRS-1) Treated with Terlipressin Post-hoc, pooled analyses of three Phase 3 trials found HRS-1 p...

Privately held Purdue Pharma, the corporate poster child in the opioid epidemic due to its aggressive promotion of pain pill OxyContin, has agreed to plead guilty to three criminal charges under an $8B settlement with the U.S. Department of Justice the Associated Press reports.The three count...

Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha, iTunes, Stitcher and Spotify. Get ready for earnings seasonFinancial earnings will dominate the current week as the sector tries to break out of the malaise that made it an underperform...

Mallinckrodt (MNK) has voluntarily initiated Chapter 11 proceedings in the U.S. Bankruptcy Court to modify its capital structure, including restructuring portions of its debt and resolve legal liabilities.The entities that filed Chapter 11 petitions include Mallinckrodt and all of its subsidi...